Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

about

Development of a peptide conjugate vaccine for inducing therapeutic anti-IgE antibodies.Use of nonhuman primates in obstructive lung disease research – is it required?

P2860

Q39108259-5247E6D8-EE27-48DD-B917-113EE267AF5F Q57873240-9EE7B654-8D4E-4670-BAB1-53614FBFA53A

P2860

Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

Item

http://www.wikidata.org/entity/Q36933639

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

@en

type

Item

label

Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

@en

prefLabel

Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

@en

P1476

Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

@en

P2093

Brian R Champion

http://www.w3.org/2001/XMLSchema#string

Ghania Chikh

http://www.w3.org/2001/XMLSchema#string

Heather L Davis

http://www.w3.org/2001/XMLSchema#string

James D Fraser

http://www.w3.org/2001/XMLSchema#string

James R Merson

http://www.w3.org/2001/XMLSchema#string

Jennifer M Thorn

http://www.w3.org/2001/XMLSchema#string

Lu Zhang

http://www.w3.org/2001/XMLSchema#string

Michael J McCluskie

http://www.w3.org/2001/XMLSchema#string

Risini D Weeratna

http://www.w3.org/2001/XMLSchema#string

P2860

Peptide Vaccine: Progress and Challenges

Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization

Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma.

Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review

Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccine.

Therapeutic vaccines against IgE-mediated allergies.

A vaccine against nicotine for smoking cessation: a randomized controlled trial

Safety and tolerability of omalizumab.

Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective.

Circulating human IgG autoanti-IgE antibodies in asthma patients block the binding of IgE to its high affinity receptor.

P304

135-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IID3.98

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27957325

http://www.w3.org/2001/XMLSchema#string

P932

4879460

http://www.w3.org/2001/XMLSchema#string

Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

about

P2860

P2860

Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932